Literature DB >> 2960605

Fc-receptors for IgE on human lymphocytes. Detection with a rosetting assay using a recombinant human/mouse IgE antibody and characterization with monoclonal antibodies.

J C Prinz1, E P Rieber.   

Abstract

Two monoclonal antibodies, M-L25 and M-L47, were produced against the human lymphoid Fc receptor for IgE (Fc epsilon R). These antibodies were identified by their ability to selectively inhibit the binding of IgE to Fc epsilon R+ lymphoid cells as demonstrated by a newly developed IgE rosetting assay. In this method, NIP coated ox erythrocytes were complexed with a NP-specific recombinant chimeric human/mouse IgE antibody and employed as indicator cells for the detection of Fc epsilon R+ cells. The anti-Fc epsilon R antibodies stained 4.6 +/- 2.3% of normal peripheral blood mononuclear cells, 0.4 +/- 0.3% of T cells, 22.2 +/- 11.7% of the non-T cell fraction, and 34.9 +/- 2.9% of tonsil cells. Less than 0.1% of monocytes, basophilic and eosinophilic granulocytes, platelets, and thymus cells were labelled. This indicates an antigenic heterogeneity of the low affinity Fc epsilon R on lymphocytes and the Fc epsilon R found on monocytes, platelets, and eosinophilic granulocytes. The lymphoid Fc epsilon R was immunoprecipitated by M-L25 from the lysate of surface iodinated lymphoid cells. Three polypeptide chains were identified having an apparent MW of 40, 82, and 100 kd under non-reducing, and of 42, 115, and 145 kd under reducing conditions, suggesting a multichain structure of the human lymphoid Fc epsilon R.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2960605     DOI: 10.1089/hyb.1987.6.1

Source DB:  PubMed          Journal:  Hybridoma        ISSN: 0272-457X


  2 in total

1.  A role for IgE in extrinsic allergic alveolitis?

Authors:  A Pforte; U Schild; G Breyer; K Häussinger; H W Ziegler-Heitbrock
Journal:  Clin Investig       Date:  1992 Mar-Apr

2.  Expression of the Fc-receptor for IgE (Fc epsilon RII, CD23) on alveolar macrophages in extrinsic allergic alveolitis.

Authors:  A Pforte; G Breyer; J C Prinz; P Gais; G Burger; K Häussinger; E P Rieber; E Held; H W Ziegler-Heitbrock
Journal:  J Exp Med       Date:  1990-04-01       Impact factor: 14.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.